retatrutide investigational drug weight loss Medscape | The triple GLP-1/GIP/glucagon receptor agonist produced significant and A1c reduction in people Eli Lilly's weight loss drug

The main tradeoff is higher cost

The researchers created an algorithm that could predict which individuals would go on to have one of these diagnoses

This is a common concern for patients considering or taking GLP-1 receptor agonists such as semaglutide (Ozempic, Wegovy) or liraglutide (Saxenda, Victoza) for type 2 diabetes or weight management

A refined approach focuses on restoring volume while preserving your natural features

Interestingly, Fetoni and colleagues have recently identified endogenous coenzymes Q 9 and Q 10 to be reduced in the cochlea after exposure to 60 min of 100 dB SPL sound for 10 consecutive days (Fetoni et al., 10, beginning 3 days prior to the noise insult, has been shown to improve hearing threshold, reducing HC bundle disorientation and SGN loss in the mid-cochlear turn, likely due to lowered noise-induced oxidative stress on the sensorineural tissues

Help protect your patients by reducing their risk of CKD progression 1,2 1,2 For adults with T2D, for the primary composite endpoint: Time to first occurrence of 50% sustained eGFR decline, kidney failure (sustained eGFR 100 mg/g and 300 mg/g at baseline)